Literature DB >> 29893325

Oral submucous fibrosis: A clinico-histopathological correlational study.

Sudharani Basawaraj Biradar1, Anita Dnyanoba Munde1, Basawaraj Chanabasappa Biradar2, Safia Shoeb Shaik1, Shweta Mishra3.   

Abstract

AIM OF THE STUDY: The aim of this study was to correlate the clinical staging (clinical severity) with the histopathological staging (histopathological changes) of oral submucous fibrosis (OSF) patients, which would further assist the clinicians to formulate a definite treatment plan.
MATERIALS AND METHODS: The study group consisted of 50 subjects who were clinically and histologically diagnosed as OSF. Detailed information was gathered in a pretested proforma with emphasis on the various addictions. The clinical findings were noted; punch biopsy was performed followed by histological examination. Clinical and histological staging were divided into four stages, as Stages I-IV according to Khanna and Andrade classification.
RESULTS: The 50 subjects were in the age range of 18-70 years, of which 20 patients were in clinical Group III, 15 were in histopathological stage III, 2, 1, and 2 in Stage II, Stage I, and Stage IV, respectively, out of 5 patients in clinical Group IV, 4 were in histopathological staging IV and 1 was in Stage III, out of 5 patients in clinical Group I, 3 and 2 were in histologic Stages II and I, respectively. Statistical analysis with Chi-square test showed high significance with P < 0.001.
CONCLUSION: The correlation of clinical and histopathological staging was found to be highly significant, thus suggesting that the subject with clinically advanced OSF had extensive fibrosis histologically.

Entities:  

Keywords:  Areca nut; clinical staging; histopathologic staging; oral submucous fibrosis

Mesh:

Year:  2018        PMID: 29893325     DOI: 10.4103/0973-1482.176177

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  A novel histological grading system for minor salivary gland involvement in oral submucous fibrosis patients with clinico-pathological validation.

Authors:  Yashwant Ingle; Gargi S Sarode; Sachin C Sarode
Journal:  J Oral Biol Craniofac Res       Date:  2021-09-09

2.  Reduction in and Preventive Effects for Oral-Cancer Risk with Antidepressant Treatment.

Authors:  Chia-Min Chung; Tzer-Min Kuo; Kun-Tu Yeh; Chien-Hung Lee; Ying-Chin Ko
Journal:  J Pers Med       Date:  2021-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.